Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
about
Uncovering the role of p53 splice variants in human malignancy: a clinical perspectivep53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptGene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinomaThe isoforms of the p53 proteinp53 Isoforms: An Intracellular Microprocessor?p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damagep53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.Colorectal carcinoma-associated antigen Ca-Hb3 detected by one-dimensional SDS-polyacrylamide gel electrophoresis and liquid chromatography-tandem mass spectrometryAlternative splicing in cancer: implications for biology and therapy.p53 Isoforms: Key Regulators of the Cell Fate Decision.Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis.Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.
P2860
Q27015641-DDC6CC16-7AC8-4917-B8E0-D949D517A59FQ28079390-67C89F3F-172A-49A6-A033-CEB9E6902AA1Q33641747-D268A7CA-9897-4023-BF2A-1BEF38F725C1Q33693832-87D8AD8D-DDDD-4137-A123-B01479CC8F0DQ34202703-E6D45A55-B579-4F48-82A5-EB2AB68FC908Q34575503-DA63C5A8-FF4D-4B32-AAC7-075B84C33B3DQ35029530-16D152B4-798B-40D6-8BB7-6EBFD4AE3710Q35623109-B5410D36-FC18-4245-B693-C5FD2CE07A99Q37220894-5B3EE6D2-6D85-4426-99C3-3117A08AB772Q38179828-87CBCE27-93F4-4CE8-9DEF-0F370A12ED09Q38708506-CA65785B-B81E-41CC-8A11-437FF1264FA9Q39236844-149982EE-39F4-4EB4-AD5A-C1D77EF904E2Q43184300-72A4E2F0-CA85-42CC-8D0B-D228AF3F7644Q50858313-2722B079-F162-4E3E-86E5-FB9220865E54Q55452619-79B0164A-65A2-4652-9679-03D38880A067
P2860
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@ast
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@en
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@nl
type
label
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@ast
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@en
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@nl
prefLabel
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@ast
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@en
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@nl
P2093
P2860
P1476
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
@en
P2093
A Maria Codegoni
Anna Compagnoni
Dario Cattaneo
Eleonora Marrazzo
Massimo Broggini
Mauro Signorelli
Mirko Marabese
Pietro Mariani
Roldano Fossati
Sergio Marchini
P2860
P304
P356
10.1016/J.EJCA.2007.10.011
P577
2007-11-26T00:00:00Z